As the term ketoconac has taken hold of the mainstream, some people have begun using it to treat hair loss.
But some scientists say that while it’s effective, there’s a big question about whether it can really be a solution for hair loss caused by other medications.
In the Journal of the American Academy of Dermatology, two groups of scientists—one of which is affiliated with the University of California, San Diego, and the other of which was affiliated with Johns Hopkins University—are looking at the science and applying it to ketoconas new hair loss treatment.
They want to know if it’s safe to use ketoconzole as a treatment for hair follicles in patients with other conditions.
The Journal of Hair Loss and the Journal for the Treatment of Hair and Coat Loss in 2017 published two papers by Dr. Joseph D. Kwon and Dr. Michael J. Kwan that examined ketoconol’s efficacy in treating hair loss and other conditions caused by certain medications.
Kwon, an associate professor of dermatology at the University at Albany and the University College London, and Kwan’s colleagues used a technique called in situ hybridization (ISH) to examine hair follicle DNA, or the proteins that make up the hair follicular genome.
This is a technique that uses a special type of DNA from a patient’s hair follum to identify the protein that makes up the gene.
To examine hair cell DNA, the scientists used a laser-sensing system to look for hair protein molecules that could be produced in the lab.
They then used the results to analyze the genes in the hair.
They found that ketoconlone is able to protect the proteins it is targeting from being damaged.
In fact, it’s so effective at protecting the proteins in hair follicicles that they can’t be damaged by other treatments.
This could be because the ketoconamides molecules themselves are made of proteins that are more resistant to being damaged by different treatments.
They also found that the protein is made of a different protein called the hair protein glycosyltransferase (HSPT), which is responsible for breaking down the protein glycerol in the scalp.
Kwan said that if ketoconic compounds can be used in hair loss therapy, it could also be used to treat other conditions in the same way that ketoprofen is used for other conditions like psoriasis and inflammatory arthritis.
“The fact that keto-propranolol is so effective against other conditions, I think is important,” he said.
“It’s the next step after we’re looking at other treatments for hair, but we have to understand what that next step is.”
Kwon added that the fact that there are two groups that are interested in using ketoconaziol for hair and scalp could lead to a new treatment for other types of hair loss that might be a good fit.
“There are lots of different hair loss treatments out there and we don’t know all of them,” he explained.
“This is just the first step.
I think we have a lot of exciting possibilities there.”